elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36126134-AAC57B7A-0DC9-42A3-A4F9-DBF586CDF500
Q36126134-AAC57B7A-0DC9-42A3-A4F9-DBF586CDF500
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36126134-AAC57B7A-0DC9-42A3-A4F9-DBF586CDF500
Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor
P2860
Q36126134-AAC57B7A-0DC9-42A3-A4F9-DBF586CDF500
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36126134-AAC57B7A-0DC9-42A3-A4F9-DBF586CDF500
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0ee0a8fa40c37da1cce8b763c8a1da64475f9f2b
P2860
Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours